Related Experiment Videos
Tyrphostin AG 494 blocks Cdk2 activation
1Department of Biological Chemistry, Alexander Silverman Institute of Life Sciences, The Hebrew University of Jerusalem, Givat Ram, Israel.
Abstract:
We have previously shown that the EGFR kinase selective tyrphostin AG 494 fails to inhibit EGFR kinase in intact cells. Yet, AG 494 proved to inhibit EGF- or serum-induced cell proliferation (Osherov et al., J. Biol. Chem. 268 (1993) 11134-11142). In this preliminary communication we show that AG 494 as well as its close analogs AG 490 and AG 555 block Cdk2 activation. In contrast, AG 1478, a more selective EGFR kinase blocker which is also active as EGFR kinase blocker in intact cells, fails to do so. AG 494 exerts its full inhibitory activity on Cdk2 activation even when added 20 h subsequent to EGF addition when Cdk2 activation is maximal. The inhibitory activity on Cdk2 activation parallels its DNA synthesis inhibitory activity, strongly suggesting that its target is one of the molecular mechanisms involved in Cdk2 activation. AG 494 and its analogs may become useful lead compounds for the development of drugs aimed at the cell cycle machinery.
Insights
The tyrphostin AG 494 compound inhibits cell proliferation by blocking Cdk2 activation, not EGFR kinase, in intact cells. This finding suggests AG 494 and analogs are potential drug leads for cell cycle machinery targets.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- The EGFR kinase selective tyrphostin AG 494 inhibits cell proliferation but not EGFR kinase in intact cells.
- This suggests a mechanism independent of direct EGFR kinase inhibition for AG 494's anti-proliferative effects.
Purpose of the Study:
- To investigate the molecular mechanism by which AG 494 inhibits cell proliferation.
- To evaluate the effect of AG 494 and its analogs on Cdk2 activation.
Main Methods:
- Treatment of cells with AG 494, AG 490, AG 555, and AG 1478.
- Assessment of Cdk2 activation and DNA synthesis.
- Comparison of inhibitory effects on Cdk2 activation and cell proliferation.
Main Results:
- AG 494, AG 490, and AG 555 block Cdk2 activation, while AG 1478 does not.
- AG 494 inhibits Cdk2 activation even when added 20 hours after EGF stimulation.
- Inhibitory activity on Cdk2 activation correlates with DNA synthesis inhibition.
Conclusions:
- AG 494's anti-proliferative effect is mediated by Cdk2 activation inhibition, not direct EGFR kinase blockade.
- AG 494 and its analogs show promise as lead compounds for developing drugs targeting the cell cycle machinery.